Biotechnology News

August 19, 2014

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that it has received notice of the early termination of the waiting period for U.S. antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act...

August 19, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced that it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with BRILINTA® (ticagrelor) tablets....

August 19, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US/Non-UK/Non-Canadian Media Boehringer Ingelheim today announces that the first patients have been enrolled in the company’s new international phase III study, RE-DUAL PCITM.1 The study will evaluate...

August 19, 2014

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Probi (STO:PROB) SECOND QUARTER OF 2014 •NET SALES amounted to MSEK 31.9 (26.5). •OPERATING PROFIT totalled MSEK 5.3 (4.6). •PROFIT AFTER TAX amounted to MSEK4.3 (3.8). •PROFIT AFTER TAX PER SHARE...

August 18, 2014

SAN DIEGO--(BUSINESS WIRE)--Using a fundraising approach seldom seen in the life sciences sector, Batu Biologics, an immunotherapy company working to develop the first anti-angiogenic cancer vaccine, has successfully raised $100,000 through the...

August 18, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2014 at 12:25 p.m. (CT). The live webcast of Baxter’s...

August 18, 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (NYSE MKT:FCSC), an autologous cell therapy company focused on developing first-in class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today...

August 18, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien announced today the publication of the DEFINITIVE LE study, which demonstrated directional atherectomy is safe and effective as a frontline therapy for the treatment of PAD.

August 18, 2014

WAUWATOSA, Wis.--(BUSINESS WIRE)--GE Healthcare introduces the Vscan with Dual Probe with the first of its kind 2-in-1 probe to give healthcare providers more uses for pocket ultrasound. This powerful pocket-sized ultrasound tool houses two...

August 18, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (Nasdaq:INSM) announced the closing of a $115.1 million underwritten public offering of 10,235,000 shares of common stock, including 1,335,000 shares of common stock which were issued...

August 18, 2014

BOSTON--(BUSINESS WIRE)--On August 18, 2014, H&Q Life Sciences Investors declared a stock distribution of $0.45 per share. The record date for the stock distribution is August 29, 2014 and the payable date is September 30, 2014. The Fund will...

August 18, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Comprehend today announced it has secured $21 million in Series B financing to accelerate clinical development through its cloud-based business intelligence solutions.

August 18, 2014

CHICAGO--(BUSINESS WIRE)--GTCR, a leading private equity firm, today announced that it has completed the previously announced acquisition of Cole-Parmer Instrument Company (“Cole-Parmer” or the “Business”) from Thermo Fisher Scientific Inc. (NYSE...

August 18, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Signs Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Industry, and Sinopharm A-THINK Pharmaceutical Co., Ltd.

August 18, 2014

TUCKER, Ga. & ROCKVILLE, Md.--(BUSINESS WIRE)--ABL contracted by Expression Therapeutics for cell line development. ABL will adapt a cell line engineered to produce a Factor VIII replacement product to animal origin-free growth conditions....

August 18, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that Jim Hindman has been named Executive Vice President, Finance and Business Development, Chief Financial Officer, effective immediately....

August 18, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its Cole-Parmer customer channel business to private equity firm GTCR LLC for...

August 18, 2014

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces Health Canada acceptance of GENETIC-AF clinical trial application. Canadian site activation for atrial fibrillation clinical trial to begin in 2014.

August 18, 2014

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the second...

August 18, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced it has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for palbociclib. This NDA requests FDA approval of palbociclib, in...

August 18, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--Life science researchers who want to expand their capabilities beyond traditional cell counting instruments can now do so with the Countess II FL, a next-generation, bench-top assay instrument.

August 18, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that Mark Perrin, InVivo’s Chief Executive Officer, is scheduled to present to investors at the 16th Annual Rodman & Renshaw Healthcare Conference to...

August 18, 2014

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Gerard “Gerry” Watts to fill a newly-created position as Chief Operations Officer, effective today. “With his expertise in profit and supply chain...

August 18, 2014

PORTLAND, Ore.--(BUSINESS WIRE)--NIH Awards Sedia Biosciences $195,490 SBIR Phase I Grant to develop a Rapid HIV-1 Incidence Assay. The assay could expand HIV incidence testing and improve patient case management.

August 18, 2014

BASKING RIDGE, N.J.--(BUSINESS WIRE)--electroCore has appointed Piper Jaffray to assist in discussions with pharma companies on commercialization of its non-invasive vagus nerve (nVNS) stimulation therapy.

August 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Read about BIOGEN IDEC’s newly approved PLEGRIDY™ (PEGINTERFERON BETA-1A) for Relapsing Multiple Sclerosis Treatment.

August 15, 2014

NEW YORK--(BUSINESS WIRE)--Pragma Pharmaceuticals is pleased to announce that it is re-launching Moxatag® 775 mg (amoxicillin extended-release tablets), the only once-a-day amoxicillin. Pragma acquired Moxatag from Shionogi Inc. in March 2014 and...

August 15, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Overcoming the limitations of photosynthesis, Joule has successfully co-opted nature’s primary energy capture process at unprecedented efficiencies for direct, continuous fuel production. This includes the...

August 15, 2014

HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley & Sons (NYSE: JWa and JWb) will provide free access to biomedical literature in support of the Ebola outbreak relief efforts in West Africa, aiding responders across the affected population. As part...

August 15, 2014

--(BUSINESS WIRE)--Asuragen is a molecular diagnostics company using genomics to drive better patient management in oncology and genetic diseases through world leading clinical testing solutions. The company uses a breadth of technologies and...

August 15, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta (STO:EKTAB) will publish its Interim Report 2014/15 on August 28, as per: · The report will be published at 13:00 CET. · Elekta will host a telephone conference at 13:45-14:30 CET with Niklas...

August 15, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Enrollment to the ongoing clinical phase IIa study with NeuroVive’s (STO:NVP) drug candidate NeuroSTAT® for treating patients with severe traumatic brain injury (TBI) is continuing, and another two...

August 15, 2014

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Vestiage™, Inc. (“VEST”), the healthy-aging company, announced today that its recently launched national advertising campaign is producing strong results driving web traffic to all time highs for the...

August 15, 2014 (All day)

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic, and consumer health products, today announced that it has appointed Jack...

August 14, 2014

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma (OTCQB: TRGM) Reports promising Q2 2014 financial results. The company showed significant improvements in revenue, gross profit, and adjusted EBITDA compared to Q2 2013.

August 14, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bivalent recombinant LP2086 (rLP2086), the company’s vaccine...

August 14, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Announces Second Quarter and Year-to-Date 2014 Financial Results

August 14, 2014

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis today announced the appointment of Paul Herendeen as its new Executive Vice President and Chief Financial Officer (EVP & CFO), completing a leadership transition that began in April

August 14, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported orders of $1.74 billion, up 9 percent over one year ago, for the third fiscal quarter ended July 31, 2014, and revenues of $1.77 billion, up 7 percent...

August 14, 2014

CHICAGO--(BUSINESS WIRE)--RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, today reported on its cash balance as of June 30,...

August 14, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing Tcelna® (imilecleucel-T), a novel T-cell immunotherapy for the treatment of Multiple Sclerosis (MS), today reported financial...

August 14, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Avastin® (bevacizumab) in combination with paclitaxel and...

August 14, 2014

MADISON, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes LLC has signed a non-exclusive letter of intent with GE Healthcare, marking further progress toward establishing a domestic source of the radioisotope molybdenum-99.

August 14, 2014

PORTSMOUTH, N.H.--(BUSINESS WIRE)--Leading Global Compliance and Transparency Solution Provider for Life Sciences will Use Funds to Add to Product Portfolio, Services and Talent.

August 14, 2014

VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics, a global leader in cochlear implant technology, announced the launch of two apps designed to guide the development of listening and language skills in children with hearing loss.